FDA
approval
· 2017-01-05
FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
Summary
FDA approved a supplemental application for Accord Healthcare, Inc. to market oxybutynin chloride as a generic product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)